Hewlett Packard Enterprise announced that Frank D'Amelio, former executive vice president and CFO of Pfizer Inc., has been appointed to company's Board of Directors, effective January 10, 2023. D'Amelio will also serve as a member of the Board's Audit Committee. D'Amelio is a distinguished leader who has been regularly named one of America's top CFOs.

During his tenure as CFO at Pfizer, he was instrumental in leading a multi-year transformation and increased the company's market capitalization by approximately $165 billion. In addition to his role as CFO at Pfizer, D'Amelio was also responsible for Global Supply from 2018 to 2021, which included the manufacturing and distribution of the COVID-19 vaccine. Prior to joining the healthcare sector at Pfizer, D'Amelio worked in senior executive roles in the communications industry, including serving as Chief Operating Officer, Chief Administrative Officer, and Chief Financial Officer during his tenure at Lucent Technologies Inc., which merged with Alcatel S.A. in 2006 to form Alcatel-Lucent.

D'Amelio also currently serves as a board director for Humana Inc. and Zoetis Inc.